CN Patent

CN104725362B — 吡唑基喹喔啉激酶抑制剂

Assigned to Astex Therapeutics Ltd · Expires 2017-04-12 · 9y expired

What this patent protects

本发明涉及一种吡唑基喹喔啉激酶抑制剂。具体而言，本发明涉及新的喹喔啉衍生的化合物、含有所述化合物的药物组合物、制备所述化合物的方法和所述化合物在治疗疾病中的用途，例如，癌症。

USPTO Abstract

本发明涉及一种吡唑基喹喔啉激酶抑制剂。具体而言，本发明涉及新的喹喔啉衍生的化合物、含有所述化合物的药物组合物、制备所述化合物的方法和所述化合物在治疗疾病中的用途，例如，癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN104725362B
Jurisdiction
CN
Classification
—
Expires
2017-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Astex Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.